DXS International plc Dxs International Plc : Statement Re: Exercise Of Warrants
03 May 2016 - 2:30PM
UK Regulatory
TIDMDXSP
DXS INTERNATIONAL PLC
Exercise of Warrants
The Board of DXS International Plc ("DXS" or the "Company"), the ISDX
quoted developer and supplier of clinical decision support systems to
Clinical Commissioning Groups, GPs, doctors and healthcare professionals,
is pleased to announce that it received Notices of Exercise from current
warrant holders in respect of 480,000 warrants on 30(th) April. Of these
warrants 400,000 were exercised at 10p per ordinary share and 80,000
were exercised at 15p per ordinary share.
The Company issued 480,000 new Ordinary Shares on 30(th) April to the
exercising warrant holders and following this issue the issued share
capital of the Company is now 33,396,416 ordinary shares. This figure
may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interests
in, or change to their interest in, the Company under the FCA's
Disclosure and Transparency Rules
The Company has not received Notices of Exercise in respect of the
remaining warrants that expired on 30(th) April. The number of warrants
outstanding is therefore reduced by a total of 360,000.
One of the exercising warrant holders, Richard Gathercole, will, after
the issue of 200,000 new ordinary shares pursuant to this exercise, be
beneficially interested in 1,251,667 ordinary shares representing 3.75%
per cent. of the total ordinary shares in issue. The other exercising
warrant holder, John Godley, will, after the issue of 280,000 new
ordinary shares pursuant to this exercise, be beneficially interested in
1,196,667 ordinary shares representing 3.58% per cent. of the total
ordinary shares in issue
David Immelman commented "I am delighted that these long standing
shareholders have decided to exercise their warrants and continue to
support the Company. "
The Directors of DXS International plc accept responsibility for this
announcement
Contacts:
David Immelman, CE0 01252 719800
DXS International Plc
www.dxs-systems.com
Corporate Adviser
City & Merchant Ltd
David Papworth 020 7101 7676
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted
NHS sources, to doctors, nurses and pharmacists in their workflow and
during the patient consultation. This effective clinical decision
support ultimately translates to improved healthcare outcomes delivered
more cost effectively which should significantly contribute towards the
NHS achieving its projected efficiency savings.
This announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: DXS International plc via Globenewswire
HUG#2009455
http://www.dxs-systems.com/
(END) Dow Jones Newswires
May 03, 2016 09:30 ET (13:30 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.